Results 131 to 140 of about 338,361 (228)
In this autumn issue of the JSSE, we are pleased to present five original articles. These contributions deal with social science education in different contexts and from different educational settings, reminding the reader of the heterogeneity of our ...
Jan Löfström +2 more
doaj
Manipulating DNA repair and the DNA damage response to improve cancer therapy. [PDF]
Lan L, Fouquerel E.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Fiscal decentralization highlights the importance of central government transfers, which aim to reduce income disparities and promote regional development.
Adolf Z. D. Siahay
doaj
Editorial: Metabolism in the tumour microenvironment: implications for pathogenesis and therapeutics. [PDF]
Rasheed A, Fontana F.
europepmc +1 more source
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu +10 more
wiley +1 more source
Mapping the research landscape of minor cannabinoids: a bibliometric analysis of research trends and hotspots. [PDF]
Abbou H, Belyamani L, Eljaoudi R.
europepmc +1 more source
NKCC1: A key regulator of glioblastoma progression
Glioblastoma (GBM) progression is driven by disrupted chloride cotransporter homeostasis. NKCC1 is highly expressed in stem‐like, astrocytic, and progenitor cells, correlating with earlier recurrence, while overall survival remains unaffected. NKCC1 serves as a prognostic marker and potential therapeutic target, linking chloride transporter imbalance ...
Anja Thomsen +5 more
wiley +1 more source
Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity
Core–shell polycationic PURE dendrimers were tested in TNBC‐derived tumor models. Both formulations selectively targeted TNBC and effectively reduced tumor volume. PUREG4‐OEI48 suppressed tumor growth without detectable toxicity, whereas PUREG4‐OCEI24, despite showing efficacy, induced hepatic toxicity.
Adriana Cruz +9 more
wiley +1 more source
NeuroConText: Contrastive learning for neuroscience meta-analysis with rich text representation. [PDF]
Ghayem F +4 more
europepmc +1 more source

